Biosimilars Market by type (Protein, Insulin, Human Growth Hormones, Granulocyte Colony-stimulating Factor (G-CSF), Interferons, Recombinant Glycosylated Proteins, Erythropoietin, Monoclonal Antibodies, Follitropin, Recombinant Peptides, Glucagon, Calcitonin), by Technology (, Mass Spectroscopy, Chromatography and Others), by Application (Oncology and Blood Diseases, Growth Hormone Deficiencies and Others), by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Biosimilars Market by type (Protein, Insulin, Human Growth Hormones, Granulocyte Colony-stimulating Factor (G-CSF), Interferons, Recombinant Glycosylated Proteins, Erythropoietin, Monoclonal Antibodies, Follitropin, Recombinant Peptides, Glucagon, Calcitonin), by Technology (, Mass Spectroscopy, Chromatography and Others), by Application (Oncology and Blood Diseases, Growth Hormone Deficiencies and Others), by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 1142 | Pages: 179 | November 2016 | Region: Global


Global Biosimilars Market was worth $4.76 billion in 2016 and estimated to be growing at a CAGR of 36%, to reach $22.15 billion by 2021. Biosimilars are emerging as one of the most important sector in the healthcare industry. With increasing healthcare costs, biosimilars are being looked upon as an affordable treatment option. Growing economies are observing comprehensive growth in biosimilars industry from demanding clinical needs of therapeutics. Rise in GDP and healthcare expenditures, and the demand for cost effective therapeutics solution has resulted in the growth of this market.

Biosimilars are made using living cells that treat disease, by recombinant DNA technology and controlled gene expression. Most biosimilars are derived from bacteria, viruses, plants and animals. Biosimilar drugs are used in prevention and cure of various diseases such as rheumatoid arthritis, cancer, chronic kidney failure, oncology, diabetes, heart attacks, autoimmune diseases, growth hormone deficiency, and infectious disease.

Biosimilars offer a cheaper alternative for other biological and synthetic drugs. Across the world, the biosimilars market is driven by aging population and increasing rates of diabetes and chronic disorders. Government support and initiatives play a crucial role. Emerging pharmaceutical markets and lenient government regulations provide some of the major openings this is market. In addition, increased co-operation between manufacturing companies, and the outsourcing of biosimilar products are acting as an impetus for biosimilars market. However, high manufacturing cost and complexity, and the availability of low priced generic drugs in the market are some of the major restraints of biosimilars market are facing.

Based on product types, biosimilars are classified into Protein, Insulin, Human Growth Hormones, Granulocyte Colony-stimulating Factor (G-CSF), Interferons, Recombinant Glycosylated Proteins, Erythropoietin, Monoclonal Antibodies, Follitropin, Recombinant Peptides, Glucagon and Calcitonin. By application, they have been segemented into chronic and autoimmune diseases, blood disorders, oncology and growth hormone deficiency. Furthermore, based on geography the market is segmented into various regions namely North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. Europe is undoubtedly the largest market, followed by North America and Asia-Pacific regions. India and China are estimated to grow the fastest. Other countries such as the U.S., Brazil and South Korea, are also expected to record high growth over the next five years.

Some of the major players in the biosimilars market are Sandoz International GmbH, Wockhardt Ltd, Hospira, Inc., Teva Pharmaceutical Industries Ltd. Dr. Reddy’s Laboratories, Biocon Limited, Mylan, Inc., Zydus Cadila, Celltrion Inc., Roche Diagnostics and Cipla Ltd.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 Protein     

                                5.1.2 Insulin       

                                5.1.3 Human Growth Hormones

                                5.1.4 Granulocyte Colony-stimulating Factor (G-CSF)       

                                5.1.5 Interferons             

                                5.1.6 Recombinant Glycosylated Proteins             

                                5.1.7 Erythropoietin       

                                5.1.8 Monoclonal Antibodies     

                                5.1.9 Follitropin

                                5.1.10 Recombinant Peptides    

                                5.1.11 Glucagon               

                                5.1.12 Calcitonin              

                5.2 By Technology                          

                                5.2.1 Mass Spectroscopy             

                                5.2.2 Chromatography  

                                5.2.3 Monoclonal Antibody Technology

                                5.2.4 Recombinant DNA Technology       

                                5.2.5 Nuclear magnetic resonance (NMR) technology     

                                5.2.6 Electrophoresis     

                                5.2.7 Bioassay   

                5.3 By Application                           

                                5.3.1 Oncology diseases

                                5.3.2 Blood disorders    

                                5.3.3 Growth hormone deficiencies        

                                5.3.4 Chronic and autoimmune diseases

                                5.3.5 Others      

6. Geographical Analysis                                              

                6.1 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.2 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy           

                                6.2.6 France      

                6.3 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan        

                                6.3.5 South Korea           

                                6.3.6 Australia  

                6.4 Latin America                            

                                6.4.1 Introduction           

                                6.4.2 Brazil         

                                6.4.3 Argentina

                                6.4.4 Mexico     

                6.5 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa        

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Sandoz International GmbH                

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Wockhardt                 

                8.3 Hospira                        

                8.4 Teva Pharmaceutical Industries                         

                8.5 Dr. Reddy’s Laboratories                      

                8.6 Biocon                          

                8.7 Mylan                           

                8.8 Zydus Cadila                               

                8.9 Celltrion                       

                8.10 Roche Diagnostics                 

                8.11 Cipla                            

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

                                               

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Global Biosimilars Market By Region, From 2016-2021 ( USD Billion )
  2. Global Biosimilars Market By Type, From 2016-2021 ( USD Billion )
  3. Global Protein Market By Region, From 2016-2021 ( USD Billion )
  4. Global Insulin Market By Region, From 2016-2021 ( USD Billion )
  5. Global Human Growth Hormones Market By Region, From 2016-2021 ( USD Billion )
  6. Global Granulocyte Colony-stimulating Factor (G-CSF) Market By Region, From 2016-2021 ( USD Billion )
  7. Global Interferons Market By Region, From 2016-2021 ( USD Billion )
  8. Global Recombinant Glycosylated Proteins Market By Region, From 2016-2021 ( USD Billion )
  9. Global Erythropoietin Market By Region, From 2016-2021 ( USD Billion )
  10. Global Monoclonal Antibodies Market By Region, From 2016-2021 ( USD Billion )
  11. Global Follitropin Market By Region, From 2016-2021 ( USD Billion )
  12. Global Recombinant Peptides Market By Region, From 2016-2021 ( USD Billion )
  13. Global Glucagon Market By Region, From 2016-2021 ( USD Billion )
  14. Global Calcitonin Market By Region, From 2016-2021 ( USD Billion )
  15. Global Biosimilars Market By Technology, From 2016-2021 ( USD Billion )
  16. Global Mass Spectroscopy Market By Region, From 2016-2021 ( USD Billion )
  17. Global Chromatography Market By Region, From 2016-2021 ( USD Billion )
  18. Global Monoclonal Antibody Technology Market By Region, From 2016-2021 ( USD Billion )
  19. Global Recombinant DNA Technology Market By Region, From 2016-2021 ( USD Billion )
  20. Global Nuclear magnetic resonance (NMR) technology Market By Region, From 2016-2021 ( USD Billion )
  21. Global Electrophoresis Market By Region, From 2016-2021 ( USD Billion )
  22. Global Bioassay Market By Region, From 2016-2021 ( USD Billion )
  23. Global Biosimilars Market By Application, From 2016-2021 ( USD Billion )
  24. Global Oncology diseases Market By Region, From 2016-2021 ( USD Billion )
  25. Global Blood disorders Market By Region, From 2016-2021 ( USD Billion )
  26. Global Growth hormone deficiencies Market By Region, From 2016-2021 ( USD Billion )
  27. Global Chronic and autoimmune diseases Market By Region, From 2016-2021 ( USD Billion )
  28. Global Others Market By Region, From 2016-2021 ( USD Billion )
  29. North America Biosimilars Market By Type, From 2016-2021 ( USD Billion )
  30. North America Protein Market By Region, From 2016-2021 ( USD Billion )
  31. North America Insulin Market By Region, From 2016-2021 ( USD Billion )
  32. North America Human Growth Hormones Market By Region, From 2016-2021 ( USD Billion )
  33. North America Granulocyte Colony-stimulating Factor (G-CSF) Market By Region, From 2016-2021 ( USD Billion )
  34. North America Interferons Market By Region, From 2016-2021 ( USD Billion )
  35. North America Recombinant Glycosylated Proteins Market By Region, From 2016-2021 ( USD Billion )
  36. North America Erythropoietin Market By Region, From 2016-2021 ( USD Billion )
  37. North America Monoclonal Antibodies Market By Region, From 2016-2021 ( USD Billion )
  38. North America Follitropin Market By Region, From 2016-2021 ( USD Billion )
  39. North America Recombinant Peptides Market By Region, From 2016-2021 ( USD Billion )
  40. North America Glucagon Market By Region, From 2016-2021 ( USD Billion )
  41. North America Calcitonin Market By Region, From 2016-2021 ( USD Billion )
  42. North America Biosimilars Market By Technology, From 2016-2021 ( USD Billion )
  43. North America Mass Spectroscopy Market By Region, From 2016-2021 ( USD Billion )
  44. North America Chromatography Market By Region, From 2016-2021 ( USD Billion )
  45. North America Monoclonal Antibody Technology Market By Region, From 2016-2021 ( USD Billion )
  46. North America Recombinant DNA Technology Market By Region, From 2016-2021 ( USD Billion )
  47. North America Nuclear magnetic resonance (NMR) technology Market By Region, From 2016-2021 ( USD Billion )
  48. North America Electrophoresis Market By Region, From 2016-2021 ( USD Billion )
  49. North America Bioassay Market By Region, From 2016-2021 ( USD Billion )
  50. North America Biosimilars Market By Application, From 2016-2021 ( USD Billion )
  51. North America Oncology diseases Market By Region, From 2016-2021 ( USD Billion )
  52. North America Blood disorders Market By Region, From 2016-2021 ( USD Billion )
  53. North America Growth hormone deficiencies Market By Region, From 2016-2021 ( USD Billion )
  54. North America Chronic and autoimmune diseases Market By Region, From 2016-2021 ( USD Billion )
  55. North America Others Market By Region, From 2016-2021 ( USD Billion )
  56. United States Biosimilars Market By Type, From 2016-2021 ( USD Billion )
  57. United States Biosimilars Market By Technology, From 2016-2021 ( USD Billion )
  58. United States Biosimilars Market By Application, From 2016-2021 ( USD Billion )
  59. Canada Biosimilars Market By Type, From 2016-2021 ( USD Billion )
  60. Canada Biosimilars Market By Technology, From 2016-2021 ( USD Billion )
  61. Canada Biosimilars Market By Application, From 2016-2021 ( USD Billion )
  62. Europe Biosimilars Market By Type, From 2016-2021 ( USD Billion )
  63. Europe Protein Market By Region, From 2016-2021 ( USD Billion )
  64. Europe Insulin Market By Region, From 2016-2021 ( USD Billion )
  65. Europe Human Growth Hormones Market By Region, From 2016-2021 ( USD Billion )
  66. Europe Granulocyte Colony-stimulating Factor (G-CSF) Market By Region, From 2016-2021 ( USD Billion )
  67. Europe Interferons Market By Region, From 2016-2021 ( USD Billion )
  68. Europe Recombinant Glycosylated Proteins Market By Region, From 2016-2021 ( USD Billion )
  69. Europe Erythropoietin Market By Region, From 2016-2021 ( USD Billion )
  70. Europe Monoclonal Antibodies Market By Region, From 2016-2021 ( USD Billion )
  71. Europe Follitropin Market By Region, From 2016-2021 ( USD Billion )
  72. Europe Recombinant Peptides Market By Region, From 2016-2021 ( USD Billion )
  73. Europe Glucagon Market By Region, From 2016-2021 ( USD Billion )
  74. Europe Calcitonin Market By Region, From 2016-2021 ( USD Billion )
  75. Europe Biosimilars Market By Technology, From 2016-2021 ( USD Billion )
  76. Europe Mass Spectroscopy Market By Region, From 2016-2021 ( USD Billion )
  77. Europe Chromatography Market By Region, From 2016-2021 ( USD Billion )
  78. Europe Monoclonal Antibody Technology Market By Region, From 2016-2021 ( USD Billion )
  79. Europe Recombinant DNA Technology Market By Region, From 2016-2021 ( USD Billion )
  80. Europe Nuclear magnetic resonance (NMR) technology Market By Region, From 2016-2021 ( USD Billion )
  81. Europe Electrophoresis Market By Region, From 2016-2021 ( USD Billion )
  82. Europe Bioassay Market By Region, From 2016-2021 ( USD Billion )
  83. Europe Biosimilars Market By Application, From 2016-2021 ( USD Billion )
  84. Europe Oncology diseases Market By Region, From 2016-2021 ( USD Billion )
  85. Europe Blood disorders Market By Region, From 2016-2021 ( USD Billion )
  86. Europe Growth hormone deficiencies Market By Region, From 2016-2021 ( USD Billion )
  87. Europe Chronic and autoimmune diseases Market By Region, From 2016-2021 ( USD Billion )
  88. Europe Others Market By Region, From 2016-2021 ( USD Billion )
  89. U.K. Biosimilars Market By Type, From 2016-2021 ( USD Billion )
  90. U.K. Biosimilars Market By Technology, From 2016-2021 ( USD Billion )
  91. U.K. Biosimilars Market By Application, From 2016-2021 ( USD Billion )
  92. Germany Biosimilars Market By Type, From 2016-2021 ( USD Billion )
  93. Germany Biosimilars Market By Technology, From 2016-2021 ( USD Billion )
  94. Germany Biosimilars Market By Application, From 2016-2021 ( USD Billion )
  95. France Biosimilars Market By Type, From 2016-2021 ( USD Billion )
  96. France Biosimilars Market By Technology, From 2016-2021 ( USD Billion )
  97. France Biosimilars Market By Application, From 2016-2021 ( USD Billion )
  98. Italy Biosimilars Market By Type, From 2016-2021 ( USD Billion )
  99. Italy Biosimilars Market By Technology, From 2016-2021 ( USD Billion )
  100. Italy Biosimilars Market By Application, From 2016-2021 ( USD Billion )
  101. Spain Biosimilars Market By Type, From 2016-2021 ( USD Billion )
  102. Spain Biosimilars Market By Technology, From 2016-2021 ( USD Billion )
  103. Spain Biosimilars Market By Application, From 2016-2021 ( USD Billion )
  104. Asia-Pacific Biosimilars Market By Type, From 2016-2021 ( USD Billion )
  105. Asia-Pacific Protein Market By Region, From 2016-2021 ( USD Billion )
  106. Asia-Pacific Insulin Market By Region, From 2016-2021 ( USD Billion )
  107. Asia-Pacific Human Growth Hormones Market By Region, From 2016-2021 ( USD Billion )
  108. Asia-Pacific Granulocyte Colony-stimulating Factor (G-CSF) Market By Region, From 2016-2021 ( USD Billion )
  109. Asia-Pacific Interferons Market By Region, From 2016-2021 ( USD Billion )
  110. Asia-Pacific Recombinant Glycosylated Proteins Market By Region, From 2016-2021 ( USD Billion )
  111. Asia-Pacific Erythropoietin Market By Region, From 2016-2021 ( USD Billion )
  112. Asia-Pacific Monoclonal Antibodies Market By Region, From 2016-2021 ( USD Billion )
  113. Asia-Pacific Follitropin Market By Region, From 2016-2021 ( USD Billion )
  114. Asia-Pacific Recombinant Peptides Market By Region, From 2016-2021 ( USD Billion )
  115. Asia-Pacific Glucagon Market By Region, From 2016-2021 ( USD Billion )
  116. Asia-Pacific Calcitonin Market By Region, From 2016-2021 ( USD Billion )
  117. Asia-Pacific Biosimilars Market By Technology, From 2016-2021 ( USD Billion )
  118. Asia-Pacific Mass Spectroscopy Market By Region, From 2016-2021 ( USD Billion )
  119. Asia-Pacific Chromatography Market By Region, From 2016-2021 ( USD Billion )
  120. Asia-Pacific Monoclonal Antibody Technology Market By Region, From 2016-2021 ( USD Billion )
  121. Asia-Pacific Recombinant DNA Technology Market By Region, From 2016-2021 ( USD Billion )
  122. Asia-Pacific Nuclear magnetic resonance (NMR) technology Market By Region, From 2016-2021 ( USD Billion )
  123. Asia-Pacific Electrophoresis Market By Region, From 2016-2021 ( USD Billion )
  124. Asia-Pacific Bioassay Market By Region, From 2016-2021 ( USD Billion )
  125. Asia-Pacific Biosimilars Market By Application, From 2016-2021 ( USD Billion )
  126. Asia-Pacific Oncology diseases Market By Region, From 2016-2021 ( USD Billion )
  127. Asia-Pacific Blood disorders Market By Region, From 2016-2021 ( USD Billion )
  128. Asia-Pacific Growth hormone deficiencies Market By Region, From 2016-2021 ( USD Billion )
  129. Asia-Pacific Chronic and autoimmune diseases Market By Region, From 2016-2021 ( USD Billion )
  130. Asia-Pacific Others Market By Region, From 2016-2021 ( USD Billion )
  131. Japan Biosimilars Market By Type, From 2016-2021 ( USD Billion )
  132. Japan Biosimilars Market By Technology, From 2016-2021 ( USD Billion )
  133. Japan Biosimilars Market By Application, From 2016-2021 ( USD Billion )
  134. China Biosimilars Market By Type, From 2016-2021 ( USD Billion )
  135. China Biosimilars Market By Technology, From 2016-2021 ( USD Billion )
  136. China Biosimilars Market By Application, From 2016-2021 ( USD Billion )
  137. India Biosimilars Market By Type, From 2016-2021 ( USD Billion )
  138. India Biosimilars Market By Technology, From 2016-2021 ( USD Billion )
  139. India Biosimilars Market By Application, From 2016-2021 ( USD Billion )
  140. Latin America Biosimilars Market By Type, From 2016-2021 ( USD Billion )
  141. Latin America Protein Market By Region, From 2016-2021 ( USD Billion )
  142. Latin America Insulin Market By Region, From 2016-2021 ( USD Billion )
  143. Latin America Human Growth Hormones Market By Region, From 2016-2021 ( USD Billion )
  144. Latin America Granulocyte Colony-stimulating Factor (G-CSF) Market By Region, From 2016-2021 ( USD Billion )
  145. Latin America Interferons Market By Region, From 2016-2021 ( USD Billion )
  146. Latin America Recombinant Glycosylated Proteins Market By Region, From 2016-2021 ( USD Billion )
  147. Latin America Erythropoietin Market By Region, From 2016-2021 ( USD Billion )
  148. Latin America Monoclonal Antibodies Market By Region, From 2016-2021 ( USD Billion )
  149. Latin America Follitropin Market By Region, From 2016-2021 ( USD Billion )
  150. Latin America Recombinant Peptides Market By Region, From 2016-2021 ( USD Billion )
  151. Latin America Glucagon Market By Region, From 2016-2021 ( USD Billion )
  152. Latin America Calcitonin Market By Region, From 2016-2021 ( USD Billion )
  153. Latin America Biosimilars Market By Technology, From 2016-2021 ( USD Billion )
  154. Latin America Mass Spectroscopy Market By Region, From 2016-2021 ( USD Billion )
  155. Latin America Chromatography Market By Region, From 2016-2021 ( USD Billion )
  156. Latin America Monoclonal Antibody Technology Market By Region, From 2016-2021 ( USD Billion )
  157. Latin America Recombinant DNA Technology Market By Region, From 2016-2021 ( USD Billion )
  158. Latin America Nuclear magnetic resonance (NMR) technology Market By Region, From 2016-2021 ( USD Billion )
  159. Latin America Electrophoresis Market By Region, From 2016-2021 ( USD Billion )
  160. Latin America Bioassay Market By Region, From 2016-2021 ( USD Billion )
  161. Latin America Biosimilars Market By Application, From 2016-2021 ( USD Billion )
  162. Latin America Oncology diseases Market By Region, From 2016-2021 ( USD Billion )
  163. Latin America Blood disorders Market By Region, From 2016-2021 ( USD Billion )
  164. Latin America Growth hormone deficiencies Market By Region, From 2016-2021 ( USD Billion )
  165. Latin America Chronic and autoimmune diseases Market By Region, From 2016-2021 ( USD Billion )
  166. Latin America Others Market By Region, From 2016-2021 ( USD Billion )
  167. Brazil Biosimilars Market By Type, From 2016-2021 ( USD Billion )
  168. Brazil Biosimilars Market By Technology, From 2016-2021 ( USD Billion )
  169. Brazil Biosimilars Market By Application, From 2016-2021 ( USD Billion )
  170. Rest of Latin America Biosimilars Market By Type, From 2016-2021 ( USD Billion )
  171. Rest of Latin America Biosimilars Market By Technology, From 2016-2021 ( USD Billion )
  172. Rest of Latin America Biosimilars Market By Application, From 2016-2021 ( USD Billion )
  173. Middle East & Africa Biosimilars Market By Type, From 2016-2021 ( USD Billion )
  174. Middle East & Africa Protein Market By Region, From 2016-2021 ( USD Billion )
  175. Middle East & Africa Insulin Market By Region, From 2016-2021 ( USD Billion )
  176. Middle East & Africa Human Growth Hormones Market By Region, From 2016-2021 ( USD Billion )
  177. Middle East & Africa Granulocyte Colony-stimulating Factor (G-CSF) Market By Region, From 2016-2021 ( USD Billion )
  178. Middle East & Africa Interferons Market By Region, From 2016-2021 ( USD Billion )
  179. Middle East & Africa Recombinant Glycosylated Proteins Market By Region, From 2016-2021 ( USD Billion )
  180. Middle East & Africa Erythropoietin Market By Region, From 2016-2021 ( USD Billion )
  181. Middle East & Africa Monoclonal Antibodies Market By Region, From 2016-2021 ( USD Billion )
  182. Middle East & Africa Follitropin Market By Region, From 2016-2021 ( USD Billion )
  183. Middle East & Africa Recombinant Peptides Market By Region, From 2016-2021 ( USD Billion )
  184. Middle East & Africa Glucagon Market By Region, From 2016-2021 ( USD Billion )
  185. Middle East & Africa Calcitonin Market By Region, From 2016-2021 ( USD Billion )
  186. Middle East & Africa Biosimilars Market By Technology, From 2016-2021 ( USD Billion )
  187. Middle East & Africa Mass Spectroscopy Market By Region, From 2016-2021 ( USD Billion )
  188. Middle East & Africa Chromatography Market By Region, From 2016-2021 ( USD Billion )
  189. Middle East & Africa Monoclonal Antibody Technology Market By Region, From 2016-2021 (USD Billion)
  190. Middle East & Africa Recombinant DNA Technology Market By Region, From 2016-2021 ( USD Billion )
  191. Middle East & Africa Nuclear magnetic resonance (NMR) technology Market By Region, From 2016-2021 ( USD Billion )
  192. Middle East & Africa Electrophoresis Market By Region, From 2016-2021 ( USD Billion )
  193. Middle East & Africa Bioassay Market By Region, From 2016-2021 ( USD Billion )
  194. Middle East & Africa Biosimilars Market By Application, From 2016-2021 ( USD Billion )
  195. Middle East & Africa Oncology diseases Market By Region, From 2016-2021 ( USD Billion )
  196. Middle East & Africa Blood disorders Market By Region, From 2016-2021 ( USD Billion )
  197. Middle East & Africa Growth hormone deficiencies Market By Region, From 2016-2021 ( USD Billion )
  198. Middle East & Africa Chronic and autoimmune diseases Market By Region, From 2016-2021 ( USD Billion )
  199. Middle East & Africa Others Market By Region, From 2016-2021 ( USD Billion )
  200. Middle East Biosimilars Market By Type, From 2016-2021 ( USD Billion )
  201. Middle East Biosimilars Market By Technology, From 2016-2021 ( USD Billion )
  202. Middle East Biosimilars Market By Application, From 2016-2021 ( USD Billion )
  203. Africa Biosimilars Market By Type, From 2016-2021 ( USD Billion )
  204. Africa Biosimilars Market By Technology, From 2016-2021 ( USD Billion )
  205. Africa Biosimilars Market By Application, From 2016-2021 ( USD Billion )
Middle East and Africa Antacid Market by Submarkets (Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems(CTMS), Healthcare IT outsourcing, Immunoassay, Digital Pathology, N...
Latin America Antacid Market by Submarkets (Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems(CTMS), Healthcare IT outsourcing, Immunoassay, Digital Pathology, Next Gener...
Asia-Pacific Antacid Market by Submarkets (Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems(CTMS), Healthcare IT outsourcing, Immunoassay, Digital Pathology, Next Genera...
Europe Antacid Market by Submarkets (Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems(CTMS), Healthcare IT outsourcing, Immunoassay, Digital Pathology, Next Generation s...
North America Antacid Market by Submarkets (Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems (CTMS), Healthcare IT outsourcing, Immunoassay, Digital Pathology, Next Gene...
Antacid Market by Submarkets (Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems(CTMS), Healthcare IT outsourcing, Immunoassay, Digital Pathology, Next Generation sequenci...
Middle East and Africa Generic Drugs Market by type (Biosimilars, simple generic and super generic) by therapeutic drugs (Cardiovascular products, anti-infective products, anti-arthritis drugs, central nervous syste...
Latin America Generic Drugs Market by type (Biosimilars, simple generic and super generic) by therapeutic drugs (Cardiovascular products, anti-infective products, anti-arthritis drugs, central nervous system drugs, ...
Asia-Pacific Generic Drugs Market by type (Biosimilars, simple generic and super generic) by therapeutic drugs (Cardiovascular products, anti-infective products, anti-arthritis drugs, central nervous system drugs, a...
Europe Generic Drugs Market by type (Biosimilars, simple generic and super generic) by therapeutic drugs (Cardiovascular products, anti-infective products, anti-arthritis drugs, central nervous system drugs, anti-ca...
North America Generic Drugs Market by type (Biosimilars, simple generic and super generic) by therapeutic drugs (Cardiovascular products, anti-infective products, anti-arthritis drugs, central nervous system drugs, ...
Generic Drugs Market by type (Biosimilars, simple generic and super generic) by therapeutic drugs (Cardiovascular products, anti-infective products, anti-arthritis drugs, central nervous system drugs, anti-cancer dr...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, Kakatiya's Empire,
Jubilee Gardens, Hyderabad,
Telangana, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.